UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 290

Sortiert nach

Exploring the health of families with a child with autism

Autism : the international journal of research and practice, 2021-07, Vol.25 (5), p.1203-1215

2021

Volltextzugriff (PDF)

Antiemetic activity of the NK1 receptor antagonist GR205171 in the treatment of established postoperative nausea and vomiting after major gynaecological surgery

British journal of anaesthesia : BJA, 1999-02, Vol.82 (2), p.274-276

1999

Volltextzugriff (PDF)

Sex and hand differences in circadian wrist activity are independent from sex and hand differences in 2D:4D

Journal of circadian rhythms, 2009-10, Vol.7 (1), p.13-13

2009

Volltextzugriff (PDF)

A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients

Supportive care in cancer, 2002-04, Vol.10 (3), p.231-236

2002

Volltextzugriff (PDF)

Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy

The Lancet (British edition), 1991-08, Vol.338 (8765), p.487-490

1991

Volltextzugriff (PDF)

A multicentre, double-blind study comparing placebo, ondansetron and ondansetron plus dexamethasone for the control of cisplatin-induced delayed emesis

Annals of oncology, 1996-11, Vol.7 (9), p.945-952

1996

Volltextzugriff (PDF)

Ondansetron is more effective than metoclopramide for the treatment of opioid-induced emesis in post-surgical adult patients

European journal of anaesthesiology, 1999-10, Vol.16 (10), p.669-677

1999

Volltextzugriff (PDF)

A multicenter, double-blind comparison of i.v. and oral administration of ondansetron plus dexamethasone for acute cisplatin-induced emesis

Anti-cancer drugs, 1998-08, Vol.9 (7), p.593-598

1998

Volltextzugriff (PDF)

Ondansetron as prophylaxis for chemotherapy and radiotherapy-induced emesis in children

Oncology, 1992, Vol.49 (4), p.279

1992

Volltextzugriff (PDF)

Ondansetron compared with metoclopramide in the control of emesis and quality of life during repeated chemotherapy for breast cancer

Oncology, 1992, Vol.49 (4), p.295

1992

Volltextzugriff (PDF)

Optimum anti-emetic therapy for cisplatin induced emesis over repeat courses: Ondansetron plus dexamethasone compared with metoclopramide, dexamethasone plus lorazepam

Annals of oncology, 1996-03, Vol.7 (3), p.277-282

1996

Volltextzugriff (PDF)

The efficacy and safety of ondansetron in the prophylaxis of cancer-chemotherapy induced nausea and vomiting in children

Clinical oncology (Royal College of Radiologists (Great Britain)), 1993, Vol.5 (1), p.11-14

1993

Volltextzugriff (PDF)

Inhibition of sexual reflexes by lumbosacral injection of a GABAB agonist in the male rat

Pharmacology, biochemistry and behavior, 1988-11, Vol.31 (3), p.657-666

1988

Volltextzugriff (PDF)

Characterization of a loss-of-function mutation in the isopenicillin N synthetase gene of Acremonium chrysogenum

Gene, 1989-12, Vol.85 (1), p.267-273

1989

Volltextzugriff (PDF)

Ondansetron is more effective than metoclopramide for the treatment of opioid-induced emesis in post-surgical adult patients. Ondansetron OIE Post-Surgical Study Group

European journal of anaesthesiology, 1999-10, Vol.16 (10), p.669

1999

Volltextzugriff (PDF)

A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dosed of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients

Supportive care in cancer, 2002-04, Vol.10 (3), p.231

2002

Volltextzugriff (PDF)

A Phase II study of ondansetron as antiemetic prophylaxis in patients receiving carboplatin for advanced ovarian cancer

Annals of oncology, 1991-09, Vol.2 (8), p.607-608

1991

Volltextzugriff (PDF)

Cues Used for Localizing Food by the Gray Squirrel (Sciurus carolinensis)

Ethology, 1986-01, Vol.72 (1), p.22-30

1986

Volltextzugriff (PDF)

ANTIEMETIC ACTIVITY OF THE NK1 RECEPTOR ANTAGONIST GR205171 IN THE TREATMENT OF PONV FOLLOWING MAJOR GYNAECOLOGICAL SURGERY

Anesthesia and analgesia, 1998-02, Vol.86 (2S), p.436

1998

Volltextzugriff (PDF)

Morphogenesis and nutrition in the Memnionella-Stachybotrys group of fungi

Journal of general microbiology, 1963-03, Vol.30, p.429

MCQUADE, A B

1963

Volltextzugriff (PDF)

Origins of the nucleate organisms II

BioSystems, 1983, Vol.16 (1), p.39-55

McQuade, A.B.

1983

Volltextzugriff (PDF)

Ondansetron suppository: a randomised, double-blind, double-dummy, parallel-group comparison with oral ondansetron for the prevention of cyclophosphamide-induced emesis and nausea. The Ondansetron Suppository emesis study group

Oncology, 1997-09, Vol.54 (5), p.380

1997

Volltextzugriff (PDF)

A multicenter, double-blind comparison of i.v. and oral administration of ondansetron plus dexamethasone for acute cisplatin-induced emesis. Ondansetron Acute Emesis Study Group

Anti-cancer drugs, 1998-08, Vol.9 (7), p.593

1998

Volltextzugriff (PDF)

Isolation by affinity chromatography of neutral proteinase from Clostridium histolyticum

BBA - Enzymology, 1973-03, Vol.302 (1), p.90-94

1973

Volltextzugriff (PDF)

Ondansetron is more effective than metoclopramide for the treatment of opioid-induced emesis in post-surgical adult patients

European journal of anaesthesiology, 1999-10, Vol.16 (10), p.669-677

1999

Volltextzugriff (PDF)

1 – 25 von 290

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(256)
Mit Volltextzugriff
(230)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(289)
Japanisch
(25)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Exploring the health of families with a child with autism

Antiemetic activity of the NK1 receptor antagonist GR205171 in the treatment of established postoperative nausea and vomiting after major gynaecological surgery

Sex and hand differences in circadian wrist activity are independent from sex and hand differences in 2D:4D

A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients

Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy

A multicentre, double-blind study comparing placebo, ondansetron and ondansetron plus dexamethasone for the control of cisplatin-induced delayed emesis

Ondansetron is more effective than metoclopramide for the treatment of opioid-induced emesis in post-surgical adult patients

A multicenter, double-blind comparison of i.v. and oral administration of ondansetron plus dexamethasone for acute cisplatin-induced emesis

Ondansetron as prophylaxis for chemotherapy and radiotherapy-induced emesis in children

Ondansetron compared with metoclopramide in the control of emesis and quality of life during repeated chemotherapy for breast cancer

Optimum anti-emetic therapy for cisplatin induced emesis over repeat courses: Ondansetron plus dexamethasone compared with metoclopramide, dexamethasone plus lorazepam

The efficacy and safety of ondansetron in the prophylaxis of cancer-chemotherapy induced nausea and vomiting in children

Inhibition of sexual reflexes by lumbosacral injection of a GABAB agonist in the male rat

Characterization of a loss-of-function mutation in the isopenicillin N synthetase gene of Acremonium chrysogenum

Ondansetron is more effective than metoclopramide for the treatment of opioid-induced emesis in post-surgical adult patients. Ondansetron OIE Post-Surgical Study Group

A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dosed of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients

A Phase II study of ondansetron as antiemetic prophylaxis in patients receiving carboplatin for advanced ovarian cancer

Cues Used for Localizing Food by the Gray Squirrel (Sciurus carolinensis)

ANTIEMETIC ACTIVITY OF THE NK1 RECEPTOR ANTAGONIST GR205171 IN THE TREATMENT OF PONV FOLLOWING MAJOR GYNAECOLOGICAL SURGERY

Morphogenesis and nutrition in the Memnionella-Stachybotrys group of fungi

Origins of the nucleate organisms II

Ondansetron suppository: a randomised, double-blind, double-dummy, parallel-group comparison with oral ondansetron for the prevention of cyclophosphamide-induced emesis and nausea. The Ondansetron Suppository emesis study group

A multicenter, double-blind comparison of i.v. and oral administration of ondansetron plus dexamethasone for acute cisplatin-induced emesis. Ondansetron Acute Emesis Study Group

Isolation by affinity chromatography of neutral proteinase from Clostridium histolyticum

Ondansetron is more effective than metoclopramide for the treatment of opioid-induced emesis in post-surgical adult patients

Suchergebnisse filtern